Drug Interaction in Infectious Diseases


The medical hurt which may be majorly prevented is drug interactions within the infectious diseases. Drug interactions represent a serious risk to patients. The approved drug product labels for anti-infective medication, direct-acting antivirals for HCV, HIV medication unveil that drug interactions gift an enormous challenge for patients and their attention suppliers. Non-CYP enzymes, CYP enzymes, and changes in stomachic pH, the ever-growing list of drug transporters could also be the reason behind interactions. There are alternative concerns that incorporate interactions thanks to food parts, flavouring medications and biological merchandise.



 


  • Fluoxetine and Phenelzine
  • Digoxin and Quinidine
  • Warfarin and Diflunisal
  • Theophylline and Ciprofloxacin

Related Conference of Drug Interaction in Infectious Diseases

October 24-25, 2022

17th World Congress on Virology, Emerging Diseases & Vaccines

Zurich, Switzerland
November 08-09, 2022

7th Rare Diseases and Orphan Drugs

London, UK
November 21-22, 2022

World Summit on Rare Disease

Rome, Italy
December 12-13, 2022

5th Pathology and Infectious Disease Conference

Prague, Czech Republic
January 23-24, 2023

10th International Congress on Infectious Diseases

Barcelona, Spain
February 20-21, 2023

6th International Conference on Rare Diseases

Amsterdam, Netherlands
August 08-09, 2023

19th World Congress on Infection Prevention and Control

Zurich, Switzerland

Drug Interaction in Infectious Diseases Conference Speakers

Recommended Sessions

Related Journals

Are you interested in